|
|
|
Insider
Information: |
Mckinstry Nancy |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
43,940 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,618,697 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
43,940 |
|
|
Total
Value |
$6,618,697 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Abbott Laboratories |
ABT |
|
2024-04-26 |
37,089 |
2012-04-27 |
0 |
Premium* |
|
Accenture Plc |
ACN |
Director |
2024-08-15 |
6,851 |
2016-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACN |
Accenture Plc |
Director |
|
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,167 |
5,415 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2021-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
5,419 |
0 |
- |
|
ABT |
Abbott Laboratories |
|
|
2021-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,499 |
27,139 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
5,421 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2021-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
5,425 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
911 |
6,340 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
5,778 |
0 |
- |
|
ABT |
Abbott Laboratories |
|
|
2022-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,602 |
33,407 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2022-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
5,780 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3 |
5,783 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
5,787 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,127 |
6,514 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
6,518 |
0 |
- |
|
ABT |
Abbott Laboratories |
|
|
2023-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,816 |
35,223 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2023-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5 |
6,521 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5 |
6,526 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5 |
6,531 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
859 |
7,390 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
6,845 |
0 |
- |
|
ABT |
Abbott Laboratories |
|
|
2024-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,866 |
37,089 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
6,847 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2024-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4 |
6,851 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2017-08-01 |
4 |
D |
$129.42 |
$121,008 |
D/D |
(935) |
2,610 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2018-02-10 |
4 |
D |
$151.89 |
$116,348 |
D/D |
(766) |
3,541 |
0 |
- |
|
ACN |
Accenture Plc |
Director |
|
2019-02-07 |
4 |
D |
$155.10 |
$127,333 |
D/D |
(821) |
4,531 |
0 |
- |
|
62 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|